Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 183 results found. Search for [ Oxford corona vaccine ]

Results 60 to 80 of 183
BusinessToday.In
November 19, 2020
Union Health Minister Harsh Wardhan asserted that India has managed despite facing scarcities of PPE kits, ventilators and N-95 masks at the start of the pandemic and is now leading the research on the vaccine globally


BusinessToday.In
November 19, 2020
This move of the government aims to honour and dignify the noble contribution made by the Corona warriors in treatment and management of COVID-19 patients. Many frontline workers lost their lives in lines of duty


BusinessToday.In
New Delhi, November 19, 2020
US pharma giants Pfizer and Moderna have released the results of clinical trials of their respective experimental coronavirus vaccines, with both reporting an efficacy of over 90 per cent. The Russian vaccine, Sputnik V has also shown encouraging results in the late-stage trials. By when will the first coronavirus vaccine be ready? Watch as the experts explain the status of the global COVID-19 vaccines, with their existing challenges.Also Read: Pfizer share rises nearly 7% after firm says COVID-19 vaccine 95% effective


BusinessToday.In
November 12, 2020
Pfizer COVID-19 vaccine would need to be stored at -70 degree Celsius, which experts believe, would be a daunting challenge even for the best medical centres


Reuters
November 10, 2020
Enough people would be vaccinated by April-May, so that the fight against the pandemic in Spain would move to another stage


Reuters
November 10, 2020
Under Bingham's leadership, the taskforce has secured supply deals for more than 350 million doses of six different COVID-19 vaccine candidates, including the Pfizer shot


BusinessToday.In
November 7, 2020
India may concentrate its efforts on Bharat Biotech's Covaxin as AstraZeneca's COVID-19 vaccine deliveries may be delayed. The months of November and December could be critical in terms of vaccine availability as a number of companies are likely to publish late-stage trial data


PTI
November 6, 2020
The World Economic Forum (WEF) said the latest survey has shown a growing reluctance to receive a vaccine, despite progress made by numerous pharmaceutical companies working on vaccine trials


BusinessToday.In
November 5, 2020
Coronavirus vaccine update: Data compiled by Duke Global Health Innovation Center said that India has pre-ordered 600 million doses of coronavirus vaccine and is now in the process of negotiation for additional 1 billion doses


BusinessToday.In
November 4, 2020
India has vaccine deals with Serum Institute of India that is manufacturing doses of the University of Oxford-AstraZeneca vaccine as well as the candidate by Novavax


Reuters
November 4, 2020
Coronavirus vaccine: \"I'm optimistic that we could reach that point before the end of this year,\" Andrew Pollard said of presenting trial results this year


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


PTI
November 1, 2020
Bharat Biotech Executive Director Sai Prasad said the price of the vaccine is yet to be determined, as the company is still looking at the cost of product development


BusinessToday.In
New Delhi, October 29, 2020
Oxford and AstraZeneca's COVID-19 vaccine trials in India are expected to be over by January, said Serum Institute of India (SII) CEO Adar Poonawalla. Sharing details of the final stage of the trial, Poonawalla said that his company had already given the first dose to more than 1,000 patients. He added that the vaccine is producing a good immune response in addition to antibodies and would be up to the UK and Indian health authorities to take a decision on how safe and effective it is. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's aims to wind up Phase-3 trials of Sputnik V by March 2021


BusinessToday.In
October 26, 2020
Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy


BusinessToday.In
October 25, 2020
COVID-19 vaccine: The deliberations by the high-level National Expert Vaccine Group on Vaccine Administration comes after Prime Minister Narendra Modi underscored the geographical span of the country


Associated Press
October 25, 2020
Coronavirus vaccine update: Testing of the AstraZeneca vaccine, developed with Oxford University, has already resumed in the United Kingdom, Brazil, South Africa and Japan


Reuters
October 22, 2020
COVID-19 vaccine: The US government is \"cautiously optimistic\" that one or two vaccines, likely from Pfizer Inc or Moderna Inc, will be available by the end of the year


BusinessToday.In
October 22, 2020
AstraZeneca vaccine trials: An AstraZeneca spokesperson, while declining to comment on the volunteer's death, said that there were no concerns that would lead the trials to be paused


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


PAGES 4 OF 10  12345